S3V Vascular Technologies Launches Nextgen Hydrophilic Coated PTCA Balloon Catheter

10 Aug 2018

S3V initiates CE certification for Nextgen Nickel Cobalt Free Drug Eluting Stent, the first of its kind in the world.

Bengaluru, Karnataka, India – Talking about the S3V, medical devices market, Dr. Bindu Dey, Secretary, Technology Development Board, Ministry of Science & Technology, Government of India said, "We were good on pharma, diagnostics, but on devices front, we lag way behind. 75 percent of medical devices used in treatment of cardiovascular treatment are imported."

She further said, "By the year 2025, the medical device market would grow to USD 50 billion and that Indian companies must take advantage of it."

Read the full article

Regarding DSM: 

...S3V has entered into a non-exclusive global License and Supply Agreement with DSM Biomedical, a global solutions provider in biomedical science and regenerative medicine, for integration of their hydrophilic coating. The material master file of this coating is available with all regulatory bodies including the USFDA. Many medical devices using these coatings have received FDA approval and CE marking. The Technology Transfer from DSM Biomedical is currently being implemented. 

Related content

  • Coatings


    Hydrophilic coatings that provide industry-leading process control and process optimization.

Read more

  • Our products

    Our products

    DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.

  • The markets we serve

    The markets we serve

    DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.

This site uses cookies to store information on your computer.

Learn more